Trademark: 79369234
Word
BARICIPAC
Status Date
Tuesday, April 2, 2024
Filing Date
Wednesday, September 21, 2022
Published for Opposition
Tuesday, April 2, 2024
5 Mineral dietary supplements for humans; Pharmaceutical drugs comprising Janus Kinase (JAK) inhibitors for the treatment of severe Coronavirus infection, alopecia areata and severe rheumatoid arthritis
Apr 2, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 2, 2024
Published For Opposition
Mar 27, 2024
Notification Of Possible Opposition Sent To Ib
Mar 27, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 13, 2024
Notification Of Notice Of Publication E-Mailed
Feb 29, 2024
Approved For Pub - Principal Register
Feb 27, 2024
Examiner's Amendment Entered
Feb 27, 2024
Notification Of Examiners Amendment E-Mailed
Feb 27, 2024
Examiners Amendment E-Mailed
Feb 27, 2024
Examiners Amendment -Written
Feb 8, 2024
Teas/Email Correspondence Entered
Feb 7, 2024
Correspondence Received In Law Office
Feb 7, 2024
Teas Response To Office Action Received
Sep 5, 2023
Refusal Processed By Ib
Aug 14, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Aug 14, 2023
Refusal Processed By Mpu
Jul 8, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Jul 7, 2023
Non-Final Action Written
Jul 3, 2023
Assigned To Examiner
May 16, 2023
Application Filing Receipt Mailed
May 12, 2023
New Application Office Supplied Data Entered
May 11, 2023
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
